2023 Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study Group Transplant Complications Working Party (TCWP) 1st listed author A Mussetti Journal Bone Marrow Transplant.
2023 Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: A case-control study on epidemiology and risk factors on behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation Group Infectious Diseases Working Party (IDWP) 1st listed author Christine Robin Journal Transplant Cell Ther.
2023 Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author V Potter Journal Bone Marrow Transplant.
2023 Role and competencies of the EBMT clinical pharmacists and clinical pharmacologists: a pan-European survey Group Pharmacist Committee 1st listed author Nick Duncan Journal Bone Marrow Transplant.
2023 Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Rémy Duléry Journal Bone Marrow Transplant.
2023 Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Carmelo Gurnari Journal Lancet Haematol.
2023 Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT Group Infectious Diseases Working Party (IDWP) 1st listed author Jan Styczynski Journal Bone Marrow Transplant.
2023 Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party Group Transplant Complications Working Party (TCWP) Lymphoma Working Party (LWP) 1st listed author Olaf Penack Journal Front Immunol.
2023 Thiotepa-based regimens are a valid alternative to total body irradiation-based reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Giorgia Battipaglia Journal Transplant Cell Ther.
2023 Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties Group Inborn Errors Working Party (IEWP) Paediatric Diseases Working Party (PDWP) 1st listed author Annamária Cseh Journal Br J Haematol.
2023 Current use of fecal microbiota transfer in patients with hematologic diseases: a survey on behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Giorgia Battipaglia Journal Bone Marrow Transplant.
2023 Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study Group Acute Leukemia Working Party (ALWP) 1st listed author Frédéric Baron Journal Br J Haematol.